Study finds a new way to shut down cancer cells’ ability to consume glucose
Credit: University of Colorado Cancer Center Cancer cells consume exorbitant amounts of glucose, a key source of energy, and shutting down this glucose consumption has...
Credit: University of Colorado Cancer Center Cancer cells consume exorbitant amounts of glucose, a key source of energy, and shutting down this glucose consumption has...
Credit: MD Anderson Cancer Center A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid...
(Boston) -- Developing diagnostic tools to "intercept" lung cancer at its earliest stage is the goal of a research team led by Boston University School...
Credit: Stuart Wolpert/UCLA Moving bus stops away from intersections would substantially reduce the amount of pollution bus riders are exposed to, UCLA scientists report today...
Madrid, November 7th, 2017 - PharmaMar (MSE:PHM) has announced today a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Zepsyre® (lurbinectedin), if...
Credit: Lancaster University Health screening campaigns which target a specific organ may lack effectiveness if the public have a poor knowledge of anatomy say researchers....
Credit: Kelvin Y. Kwan/Rutgers University-New Brunswick Want to restore hearing by injecting stem cells into the inner ear? Well, that can be a double-edged sword....
Gastric cancer is one of the five most fatal types of cancer. According to the statistics of the World Health Organization (WHO), about 750,000 patients...
Nanotechnology, the science of developing materials containing very small fibers, is having a growing influence on daily life. Now researchers have shown for the first...
Credit: University of Colorado Cancer Center Oncologists and researchers use a measurement known as Response Evaluation Criteria in Solid Tumors (RECIST) to evaluate the degree...
A new UC San Francisco-led study challenges the dogma in oncology that most cancers are caused by one dominant "driver" mutation that can be treated...
Bottom Line: Use of the blood thinner warfarin was associated with a lower risk of new cancers in people over 50. Why The Research Is...
NOVEMBER 6, 2017, NEW YORK - Ludwig Cancer Research has released the scope of its participation at the 2017 Society for Immunotherapy of Cancer (SITC)...
Credit: Salk Institute LA JOLLA -- Nov. 6, 2017 Regulatory T cells (Tregs) are the traffic cops of the immune system. They instruct other types...
Columbus, Ohio - Albert de la Chapelle, MD, PhD, Distinguished University Professor in the Department of Cancer Biology and Genetics at The Ohio State University,...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.